Product Description: Rezvilutamide (SHR3680) is an androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer[1][2].
Applications: Cancer-programmed cell death
Formula: C22H20F3N3O4S
References: [1]SangjunYoo, et al. New drugs in prostate cancer. Prostate International Volume 4, Issue 2, June 2016, Pages 37-42./[2]Veronica Mollica, et al. Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer. Cells. 2019 Jan 11;8(1):43.
CAS Number: 1572045-62-5
Molecular Weight: 479.47
Compound Purity: 99.76
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Androgen Receptor